Latest research shows Australia on track to cure Hepatitis C

Kirby Institute/UNSW – 21 February 2017

More Australians were treated for their hepatitis C infection in the first year new generation hepatitis C regimens were made available on the Pharmaceutical Benefits Schemes than in the past decade, according to a new report released today by the Kirby Institute at UNSW Sydney.

 

AMA calls for needle and syringe programs (NSPs) to be introduced in prisons

Australian Medical Association, January 9th 2017

The AMA has called for needle and syringe programs (NSPs) to be introduced in prisons and other custodial settings, to reduce the spread of Blood Borne Viruses (BBVs) including hepatitis B and C, and HIV.

AMA President, Dr Michael Gannon, said today that prevalence of BBVs is significantly higher in prisons, yet custodial facilities provide a unique opportunity to protect the health of inmates.

A new AMA position statement also warns against making transmission of a BBV a crime, and calls for specific resourcing and management of HLTV-1, a relatively unknown BBV that affects Aboriginal people in central Australia.

Read more here

Australian Government breaks silence on Hep C Inquiry

Hepatitis Australia, November 10, 2016

The Australian Government tabled its response to the Silent Disease – Inquiry into hepatitis C in Australia yesterday, but commits to little.  The Silent Disease Report was released by the House of Representatives Standing Committee on Health during June 2015 after extensive consultation with health experts, community organisations and people affected by hepatitis C.

In its response, the Government has fully agreed with just three of the ten recommendations in the report.

  • Read more here
  • Read the Government’s response here
  • Access the Silent Disease report here

Annual Report of Trends in Behaviour: Viral hepatitis

UNSW Centre for Social Research in Health, October 2016

The Annual Report of Trends in Behaviour presents data from a selection of the behavioural and social research conducted by the Centre for Social Research in Health. The report focuses in particular on studies assessing trends over time or addressing emerging issues.

The Viral Hepatitis Supplement covers a few key issues which stand out  in relation to viral hepatitis.

 

 

SpeakEasy Podcast (blood borne viruses and people who use drugs)

Annie Madden and Professor Carla Treloar have dedicated much of their lives to working in taboo fields of research: blood borne viruses and drug users. These two brilliant minds bring a wealth of expertise, knowledge and insight to real world subjects in SpeakEasy, holding engaging conversations with very special guests each episode.

Episodes so far:

  • Ep 1: We don’t know what we don’t know
  • Ep 2: Happy World Hepatitis Day: What’s happening in hep C treatment?
  • Ep 3: Men who have sex with men and hep C
  • Ep 4: In conversation with Eileen Baldry: Prisons, health and justice
  • Ep 5: The PROM Queen
  • Ep 6: Is justice really blind?

Access podcast series here